Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

First, meet Ebony, a lovable 1-year-old pit bull with the kindest heart. Ebony is a gentle soul who adores attention and is sweet to everyone she meets. Whether it's a new friend or a familiar face, ...

Cats come in a wide variety of colors and coat patterns. Some breeds are more immediately recognizable than others. Torbie ...

Freshwater environments cover about 1% of Earth's surface while accounting for more than 10% of known species. Like many ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

A clinical trial evaluating the drug fosigotifator in patients with amyotrophic lateral sclerosis has failed to meet its primary endpoint, according to topline results from the Healey ALS platform ...

Google’s ( GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug.

A fierce bird attacked a calico cat lurking under its tree territory. Footage shows the oriental magpie robin swooping down to hit the feline on the back of its head outside a cafe in Bangkok, ...

The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Critics, however, say the move is too little, too late. Other FDA and pharma news is on AI-enabled medical devices, smaller PBMs, and more.